China SXT Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $293.0K | $113.9K | $179.2K | — |
| FY2018 | $1.9M | $1.5M | $436.0K | — |
| FY2019 | $239.2K | $-296.6K | $535.8K | — |
| FY2020 | $934.2K | $803.4K | $130.8K | — |
| FY2021 | $-1.3M | $-1.4M | $78.3K | — |
| FY2022 | $268.3K | $207.4K | $60.9K | $2.3M |
| FY2023 | $-80.8K | $-80.8K | — | $554.6K |
| FY2024 | $-1.9M | $-1.9M | $7.1K | $352.1K |
| FY2025 | $-2.3M | $-2.3M | $2.0K | — |
| FY2026 | $-4.0M | $-4.0M | — | $5.3M |